FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death

FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death

Abstract Receptor-interacting serine/threonine kinase 1 (RIPK1) is a pivotal protein controlling cell death and inflammation. RIPK1 is an attractive therapeutic target, given that the inhibition of RIPK1 kinase activity has been shown to be effective in animal models of human diseases such as autoim...

Full description

Saved in:
Bibliographic Details
Main Authors: Byeong-Ju Kim, Sun Mi Hong, Hyun-Jin Noh, Jihye Kim, Su-Yeon Seon, Jeong-Eun Lee, Da-Hye Jeong, Ju-Mi Park, Sejeong Park, Sanghoon Lee, Jaewoo Kang, Dakeun Lee, Michael J. Morgan, You-Sun Kim
Format: Article
Language:English
Published: Nature Publishing Group 2025-06-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07754-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items